If anyone wants the full report on ENCY from today...email me at bisonventures@yahoo.com
PUNK $12 target small excerpt from an analyst research report today.... ⢠We continue to strongly believe the market potential for Thelin...
All I know is the price they paid for myogen was ridiculous... Ambrisentan which they claim is 'best in class' they did not even do comparative...
Separate names with a comma.